DK0595546T3 - Benzylidenderivater - Google Patents

Benzylidenderivater

Info

Publication number
DK0595546T3
DK0595546T3 DK93308369.3T DK93308369T DK0595546T3 DK 0595546 T3 DK0595546 T3 DK 0595546T3 DK 93308369 T DK93308369 T DK 93308369T DK 0595546 T3 DK0595546 T3 DK 0595546T3
Authority
DK
Denmark
Prior art keywords
hydrogen
substituted
lower alkyl
lower alkoxy
formula
Prior art date
Application number
DK93308369.3T
Other languages
English (en)
Inventor
Saichi Matsumoto
Tatsuo Tsuri
Masanao Inagaki
Hirokuni Jyoyama
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK0595546T3 publication Critical patent/DK0595546T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D291/00Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/06Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
DK93308369.3T 1992-10-28 1993-10-20 Benzylidenderivater DK0595546T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28997292 1992-10-28

Publications (1)

Publication Number Publication Date
DK0595546T3 true DK0595546T3 (da) 1996-04-15

Family

ID=17750115

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93308369.3T DK0595546T3 (da) 1992-10-28 1993-10-20 Benzylidenderivater

Country Status (14)

Country Link
US (1) US5418230A (da)
EP (1) EP0595546B1 (da)
KR (1) KR100281490B1 (da)
CN (1) CN1035614C (da)
AT (1) ATE135697T1 (da)
AU (1) AU675078B2 (da)
CA (1) CA2109498A1 (da)
DE (1) DE69301894T2 (da)
DK (1) DK0595546T3 (da)
ES (1) ES2089736T3 (da)
GR (1) GR3019395T3 (da)
HU (1) HU215924B (da)
NO (1) NO303828B1 (da)
TW (1) TW378207B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3507124B2 (ja) * 1993-05-26 2004-03-15 塩野義製薬株式会社 ベンジリデン誘導体の製造法
DE19700061A1 (de) * 1997-01-03 1998-07-09 Hoechst Schering Agrevo Gmbh Verfahren zur Herstellung von cyclischen N-Aminosulfonamiden
EP1026162A4 (en) * 1997-10-24 2001-01-17 Shionogi & Co ANTI-RHUMATISMAL AGENT
US6649645B1 (en) 1998-12-23 2003-11-18 Pharmacia Corporation Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
WO2000042997A1 (fr) * 1999-01-21 2000-07-27 Shionogi & Co., Ltd. Compositions medicinales retardees dans la decoloration de composes hydroxyle phenoliques
AU7090201A (en) 2000-07-20 2002-02-05 Lauras As Method
WO2002080974A1 (fr) * 2001-04-04 2002-10-17 Sankyo Company, Limited Utilisation medicale d'inhibiteur de production de cytokine
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
KR20050085563A (ko) 2002-12-13 2005-08-29 워너-램버트 캄파니 엘엘씨 하부요로증상을 치료하기 위한 알파-2-델타 리간드
AU2007227457B2 (en) 2006-03-17 2013-03-28 Cardioxyl Pharmaceuticals, Inc. N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
JP5308350B2 (ja) 2006-12-22 2013-10-09 レコルダーティ アイルランド リミテッド α2δリガンドおよびNSAIDを用いた下部尿路機能障害の併用療法
GB0903493D0 (en) 2009-02-27 2009-04-08 Vantia Ltd New compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH066571B2 (ja) * 1985-05-09 1994-01-26 エーザイ株式会社 2−ピロリドン誘導体
IL79648A (en) * 1985-08-09 1991-12-12 Lilly Co Eli Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation
ES2056983T3 (es) * 1988-03-21 1994-10-16 Boehringer Ingelheim Pharma Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.
NZ231534A (en) * 1988-11-29 1992-02-25 Warner Lambert Co 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions
US4895862A (en) * 1989-04-21 1990-01-23 American Home Products Corp. Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
ZA9010041B (en) * 1989-12-21 1992-08-26 Lilly Co Eli Compounds for treating inflammatory bowel disease
AU646722B2 (en) * 1991-01-21 1994-03-03 Shionogi Seiyaku Kabushiki Kaisha 3-benzylidene-1-carbamoyl-2-pyrrolidone analog

Also Published As

Publication number Publication date
HU215924B (hu) 1999-03-29
HUT70530A (en) 1995-10-30
NO933870L (no) 1994-04-29
CA2109498A1 (en) 1994-04-29
NO303828B1 (no) 1998-09-07
KR940009163A (ko) 1994-05-20
US5418230A (en) 1995-05-23
DE69301894T2 (de) 1996-11-07
CN1035614C (zh) 1997-08-13
EP0595546B1 (en) 1996-03-20
CN1092414A (zh) 1994-09-21
TW378207B (en) 2000-01-01
KR100281490B1 (ko) 2001-02-15
EP0595546A1 (en) 1994-05-04
HU9303053D0 (en) 1994-01-28
ES2089736T3 (es) 1996-10-01
AU4910793A (en) 1994-05-12
DE69301894D1 (de) 1996-04-25
GR3019395T3 (en) 1996-06-30
NO933870D0 (no) 1993-10-27
AU675078B2 (en) 1997-01-23
ATE135697T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
ATE135697T1 (de) Benzylidenderivate
GR3034398T3 (en) 2-[1',2',4'-triazol-3'-yloxymethylene]-anilides and their use as pest-control agents
ATE172201T1 (de) Morphinan-derivate und medizinische verwendung
ATE116306T1 (de) Hypoglykämische oxazolidindion-derivate.
DE69205327T2 (de) Harnstoffderivate, Verfahren zu ihrer Herstellung und diese enthaltende Medikamente.
DK1054874T3 (da) Substituerede aminophenylisoxazolinderivater, der er anvendelige som antimokrobielle midler
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
MY115311A (en) Optically active 2 - imidazoline - 5 - one derivatives as fungicides.
ATE134366T1 (de) Amid derivate von vitamin d
AU629048B2 (en) N-(-4-(phenyl)-1,2-dihydro-3-quinolyl)-N'-(phenyl) urea derivatives and their use
ATE181066T1 (de) Zwischenverbindungen zur herstellung von thioalkylthio cephalosporinderivaten
ATE324113T1 (de) Verwendung von 2,6-dialkyl-4-silyl-phenol derivaten zur behandlung von xanthom
AU623500B2 (en) Carboxylimino benzothiazole derivatives
AU4843096A (en) Arylpiperidine and arylpiperazine derivatives and medicament containing the same
KR950704333A (ko) 신규한 세펨 유도체(novel cephem derivatives)
HK1000551A1 (en) Ocular tension depressant